Shree Ganesh Remedies Ltd SGRL NSE
Company Profile ↓Company Overview
Shree Ganesh Remedies Ltd (SGRL) is a publicly traded company listed on NSE with a market capitalization of ₹909.61 Cr. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Maintains a net profit margin of 16.3%.
Carries low leverage with a debt-to-equity ratio of 0.19.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Mar 2026 Revenue of ₹109.29 Cr (+0.6% YoY); net profit ₹17.77 Cr.
- Trailing 12 Months Year-on-year growth — revenue +0.6%, earnings -23.1%.
- 5-Year Trend Long-term compounding — revenue CAGR 6.6%, profit CAGR 1.5%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 6.60% |
| 1 Year: | 0.63% |
Compounded Profit Growth
| 5 Years: | 1.45% |
| 1 Year: | -23.05% |
Stock Price Performance
| 1 Year: | +35.17% |
| 6 Months: | - |
| 3 Months: | - |
| 1 Month: | - |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
CONS
- Trading at a high P/E of 51.2.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in INR.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 24.43 Cr | 24.67 Cr | 30.32 Cr | 21.11 Cr | 33.20 Cr |
| Cost of Revenue | 5.84 Cr | 8.73 Cr | 12.59 Cr | 6.33 Cr | 14.23 Cr |
| Gross Profit | 18.59 Cr | 15.94 Cr | 17.72 Cr | 14.77 Cr | 18.97 Cr |
| Operating Expenses | 11.13 Cr | 11.06 Cr | 10.69 Cr | 10.71 Cr | 10.40 Cr |
| Operating Income | 7.45 Cr | 4.88 Cr | 7.03 Cr | 4.06 Cr | 8.57 Cr |
| EBITDA | 12.16 Cr | 7.96 Cr | 10.31 Cr | 7.39 Cr | 12.40 Cr |
| Interest Expense | 95.85 L | 94.01 L | 1.01 Cr | 73.59 L | 87.58 L |
| Pretax Income | 8.78 Cr | 4.60 Cr | 6.71 Cr | 3.98 Cr | 8.72 Cr |
| Tax Provision | 2.18 Cr | 1.15 Cr | 1.76 Cr | 89.18 L | 2.45 Cr |
| Net Income | 6.60 Cr | 3.45 Cr | 4.96 Cr | 3.09 Cr | 6.27 Cr |
| Diluted EPS | - | - | - | - | - |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 90.22 Cr | 124.80 Cr | 108.60 Cr | 109.29 Cr |
| Cost of Revenue | - | 47.16 Cr | 58.48 Cr | 35.87 Cr | 41.88 Cr |
| Gross Profit | - | 43.06 Cr | 66.32 Cr | 72.72 Cr | 67.41 Cr |
| Operating Expenses | - | 22.74 Cr | 30.62 Cr | 43.08 Cr | 42.86 Cr |
| Operating Income | - | 20.31 Cr | 35.70 Cr | 29.65 Cr | 24.55 Cr |
| EBITDA | - | 26.42 Cr | 44.82 Cr | 42.94 Cr | 38.05 Cr |
| Interest Expense | - | 4.46 L | 54.53 L | 2.08 Cr | 3.56 Cr |
| Pretax Income | - | 22.58 Cr | 38.16 Cr | 31.30 Cr | 24.01 Cr |
| Tax Provision | - | 5.56 Cr | 10.05 Cr | 8.20 Cr | 6.24 Cr |
| Net Income | - | 17.02 Cr | 28.11 Cr | 23.10 Cr | 17.77 Cr |
| Diluted EPS | - | 14.01 | 22.34 | 17.98 | 13.84 |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 143.83 Cr | 170.94 Cr | 191.94 Cr | 207.69 Cr |
| Current Assets | - | 64.29 Cr | 70.20 Cr | 77.58 Cr | 85.86 Cr |
| Cash & Equivalents | - | 8.65 Cr | 15.85 Cr | 9.94 Cr | 13.40 Cr |
| Inventory | - | 18.18 Cr | 24.99 Cr | 22.02 Cr | 24.01 Cr |
| Receivables | - | 27.92 Cr | 20.33 Cr | 22.27 Cr | 32.56 Cr |
| Total Liabilities | - | 54.90 Cr | 48.84 Cr | 46.79 Cr | 44.72 Cr |
| Current Liabilities | - | 23.74 Cr | 18.68 Cr | 16.18 Cr | 21.69 Cr |
| Long Term Debt | - | 30.93 Cr | 29.12 Cr | 29.48 Cr | 21.25 Cr |
| Total Debt | - | 33.51 Cr | 36.45 Cr | 38.38 Cr | 30.81 Cr |
| Total Equity | - | 88.94 Cr | 122.10 Cr | 145.16 Cr | 162.97 Cr |
| Shares Outstanding | - | 1.28 Cr | 1.28 Cr | 1.28 Cr | 1.28 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 17.01 Cr | 30.45 Cr | 30.66 Cr | 23.74 Cr |
| Investing Cash Flow | - | -53.57 Cr | -33.01 Cr | -35.66 Cr | -9.89 Cr |
| Financing Cash Flow | - | 41.33 Cr | 9.84 Cr | -1.09 Cr | -11.70 Cr |
| Capital Expenditure | - | -51.58 Cr | -31.14 Cr | -23.20 Cr | -16.60 Cr |
| Free Cash Flow | - | -34.57 Cr | -68.95 L | 7.47 Cr | 7.14 Cr |
| Net Change in Cash | - | 4.77 Cr | 7.28 Cr | -6.08 Cr | 2.16 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | 47.7% | 53.1% | 67.0% | 61.7% |
| Operating Margin % | - | 22.5% | 28.6% | 27.3% | 22.5% |
| Net Margin % | - | 18.9% | 22.5% | 21.3% | 16.3% |
| ROE % | - | 19.1% | 23.0% | 15.9% | 10.9% |
| ROCE % | - | 16.9% | 23.4% | 16.9% | 13.2% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for SGRL
SGRL Stock Price and Chart — NSE:SGRL - TradingView
<a href="https://news.google.com/rss/articles/CBMiWEFVX3lxTE5sbk1qRXRZR3BZZ0VNX1UwWlV2bk9TeVVOemkzd2Q4SV9YakZrUDgwakpuZmoxZEk3UThGbWFFak80WjZXWEtiaVk3ZXMxY3J1N3RJdTk5LVc?oc=5" target="_blank">SGRL Stock Price and Chart — NSE:SGRL</a> &…
Shree Ganesh Remedies Ltd. Share Price News and Analysis - Univest
<a href="https://news.google.com/rss/articles/CBMiigFBVV95cUxNVEtSYWNtRXpUb3Z2MlVHdUF6WDlrdGdHdjlZVl9uOXZiMU9fNXJRNlBkMFRXSERWUExGdTllUy0zWlluX0g5ZUpoRk9ha1E1NDdZVTg0bTdLc3BsZlpCRkVJWWZCNlhNNkRzVEhBNzI1Zmd0TFM1aUw3Z0V1WVhYdktiMjV3V3YyVFE?oc…
Shree Ganesh Remedies Ltd - equitypandit.com
<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTE5xcFRDMHdGc0F0TzZjQ29uOXk2cW1CdHZuUGY1QXBNM1RHd1drNEd4WmphSTZ6VXhfb01STDBuSkxRckZjQ3dQalVEWUxCMmk5TUtzcEFkUUxGc2k1X2c?oc=5" target="_blank">Shree Ganesh Remedies Ltd</a>  …
Technical Analysis of Shree Ganesh Remedies Ltd. (NSE:SGRL) - TradingView
<a href="https://news.google.com/rss/articles/CBMiZ0FVX3lxTFAyR0xzOFBZSWcxYmNaMk1Iakh2UFd4Qmg0RkI4WENRS1ZWcGV1cjVmSUhEcVFiV1FsallhQWNoeHNqc1NjSFF1X0xvUWMxaGJGMjRETzloQlF2X0tobFd1blBTcWZSN2s?oc=5" target="_blank">Technical Analysis of Shree …
Shree Ganesh Remedies Share Price rises 17.45%: analysis - Univest
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxON2JNbEVwVmR3SjEyZktyNmNPNjcxejdEUTRjS211cW9aWW54M2kzTUtpeHVlZ2R0SWk3NnNvUjNTU1dEaUp2WkM2WUJYVVRYdFgxWFpjNmdhU2FjcDd6UkxGa3RJT2FNYXpGYktNYXpTZDd1dDJPNGIwWjhhLUFzVnl1aE9kaXZxZGxLT0…
Shree Ganesh Remedies Ltd. (SGRL) sentiment score, message volume, participation score and buzz level - Stocktwits
<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE9wc2VtbzFOejZwQkJ4aEVpY1FwZHRrb2ZmX253VEhwQkFLZGtMd0IzZDJ2bjRmaEhlZ0ZZZjlCaWo5N21TcHNfdWJ5Znp6dE5LU0F2SGdnYVVmak4x?oc=5" target="_blank">Shree Ganesh Remedies Ltd. (SGRL) sentiment…
SGRL — Frequently Asked Questions
What is the current share price of Shree Ganesh Remedies Ltd (SGRL)?
As of 2026-09-08 04:53 IST, Shree Ganesh Remedies Ltd (SGRL) trades at ₹708.55 on NSE. Its 52-week range is ₹501.05 to ₹708.55.
What is the market capitalisation of SGRL?
Shree Ganesh Remedies Ltd (SGRL) has a market capitalisation of ₹909.61 Cr on NSE.
What is the P/E ratio of SGRL?
SGRL trades at a trailing price-to-earnings (P/E) ratio of 51.20. Its price-to-book (P/B) ratio is 4.00.
What is the return on equity (ROE) of SGRL?
SGRL has a return on equity (ROE) of 10.91%. Its return on capital employed (ROCE) is 14.83%.
Is SGRL a good stock to buy?
This page provides a data-driven analysis of Shree Ganesh Remedies Ltd (SGRL), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.